Literature DB >> 21778335

Early thoracic sympathetic block improves the treatment effect for upper extremity neuropathic pain.

Hyung Seok Yoo1, Francis Sahngun Nahm, Pyung Bok Lee, Chul Joong Lee.   

Abstract

BACKGROUND: The sympathetic nervous system has important roles in mediating many neuropathic pain conditions. A thoracic sympathetic block (TSB) is a useful therapeutic procedure for neuropathic pain in the upper extremities and thorax. However, no studies have examined the factors related to an improved therapeutic effect of TSB. In this study, we evaluated the influence of potential prognostic factors for a better TSB effect and identified clinically important prognostic factors.
METHODS: Percutaneous TSB was performed in 51 patients, under fluoroscopic guidance. Data collected for each patient included age, gender, body mass index, diagnosis, pain intensity, and symptom duration. The adjusted odds ratios and 95% confidence intervals for each variable were calculated by logistic regression.
RESULTS: TSB was more effective in patients with symptom durations of ≤1 year compared with >1 year (P = 0.006; odds ratio, 8.037; 95% confidence interval, 1.808-35.729). Patient age, gender, body mass index, diagnosis, and intensity of pre-TSB pain were not associated with TSB effectiveness.
CONCLUSION: The results showed that an earlier TSB produced a better outcome for patients with chronic pain syndrome. Thus, early TSB should be performed in patients with chronic pain in the upper extremities.

Entities:  

Mesh:

Year:  2011        PMID: 21778335     DOI: 10.1213/ANE.0b013e3182274803

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  9 in total

1.  1.5 T augmented reality navigated interventional MRI: paravertebral sympathetic plexus injections.

Authors:  David R Marker; Paweena U Thainual; Tamas Ungi; Aaron J Flammang; Gabor Fichtinger; Iulian I Iordachita; John A Carrino; Jan Fritz
Journal:  Diagn Interv Radiol       Date:  2017 May-Jun       Impact factor: 2.630

Review 2.  A regional interdependence model of musculoskeletal dysfunction: research, mechanisms, and clinical implications.

Authors:  Derrick G Sueki; Joshua A Cleland; Robert S Wainner
Journal:  J Man Manip Ther       Date:  2013-05

3.  Treatment of great auricular neuralgia with real-time ultrasound-guided great auricular nerve block: A case report and review of the literature.

Authors:  Younghoon Jeon; Saeyoung Kim
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

4.  Does the longus colli have an effect on cervical vertigo?: A retrospective study of 116 patients.

Authors:  Xiao-Ming Liu; Fu-Min Pan; Zhi-Yao Yong; Zhao-Yu Ba; Shan-Jin Wang; Zheng Liu; Wei-Dong Zhao; De-Sheng Wu
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

5.  Ultrasound-Guided Thoracic Paravertebral Block as a Sympathetic Blockade for Upper Extremity Neuropathic Pain: A Prospective Pilot Study.

Authors:  Jeongsoo Kim; Ho-Jin Lee; Young-Ju Lee; Chang-Soon Lee; Yongjae Yoo; Jee Youn Moon
Journal:  J Pain Res       Date:  2020-12-14       Impact factor: 3.133

Review 6.  Pathogenesis of painful diabetic neuropathy.

Authors:  Amir Aslam; Jaipaul Singh; Satyan Rajbhandari
Journal:  Pain Res Treat       Date:  2014-05-06

7.  Continuous Thoracic Sympathetic Ganglion Block in Complex Regional Pain Syndrome Patients with Spinal Cord Stimulation Implantation.

Authors:  EungDon Kim; MiSun Roh; SooHyang Kim; DaeHyun Jo
Journal:  Pain Res Manag       Date:  2016-03-29       Impact factor: 3.037

8.  Epidural approach to paravertebral thoracic sympathetic block as an alternative to stellate ganglion block: A case report.

Authors:  Semih Gungor; Jasmit Brar
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

9.  Evaluation of combined radiofrequency and chemical blockade of multi-segmental lumbar sympathetic ganglia in painful diabetic peripheral neuropathy.

Authors:  Yuanyuan Ding; Peng Yao; Hongxi Li; Rongjie Zhao; Guangyi Zhao
Journal:  J Pain Res       Date:  2018-07-26       Impact factor: 3.133

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.